Graypoint LLC Amgen Inc Transaction History

Graypoint LLC

$1.52 Billion
Q3 2024

A detailed history of Graypoint LLC transactions in Amgen Inc stock. As of the latest transaction made, Graypoint LLC holds 5,164 shares of AMGN stock, worth $1.45 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

5,164

Previous 5,016 2.95%

Holding current value

$1.45 Million

Previous $1.57 Million 6.13%

% of portfolio

0.11%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $45,788 - $49,932	148 Added 2.95%	5,164 $1.66 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $84,080 - $102,179	320 Added 6.81%	5,016 $1.57 Million
Q1 2024 May 02, 2024	BUY	$268.87 - $324.56 $25,004 - $30,184	93 Added 2.02%	4,696 $1.34 Million
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $23,268 - $26,249	-91 Reduced 1.94%	4,603 $1.33 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $133,813 - $166,133	612 Added 14.99%	4,694 $1.26 Million
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $7,499 - $8,867	35 Added 0.86%	4,082 $906,000
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $48,319 - $58,892	214 Added 5.58%	4,047 $978,000
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $105,124 - $133,573	-459 Reduced 10.69%	3,833 $1.01 Million
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $156,448 - $176,445	697 Added 19.39%	4,292 $967,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $52,371 - $58,279	227 Added 6.74%	3,595 $875,000
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $53,940 - $59,672	246 Added 7.88%	3,368 $814,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $2,784 - $3,186	14 Added 0.45%	3,122 $702,000
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $29,505 - $34,569	-139 Reduced 4.28%	3,108 $661,000
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $12,379 - $13,734	-53 Reduced 1.61%	3,247 $791,000
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $55,255 - $64,391	-249 Reduced 7.02%	3,300 $821,000
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $21,421 - $25,509	-99 Reduced 2.71%	3,549 $816,000
Q3 2020 Nov 02, 2020	BUY	$234.65 - $260.95 $856,003 - $951,945	3,648 New	3,648 $927,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.

Account